BLUME-JENSEN PETER (President and CEO) sold 0.4% of their position (1.71K shares) of ACRIVON THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/20/2026ACC: 0000905148-26-003836
DirectorOfficer· President and CEO
Since Mar 2026
-1.71K
Net shares
Net seller
$3.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.23K
Price / share
$2.01
Trade value
$2.47K
% of position
0.1%
8/18/2026
2.25M→2.24M
Common Stock
Indirect
Shares
−484.00
Price / share
$2.01
Trade value
$972.84
% of position
0.1%
8/18/2026
386.34K→385.86K
Total
Net shares
−1.71K
Net value
-$3.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | S · Sale | −1.23K | $2.01 | $2.47K | 0.1% | 2.25M | 2.24M |
| Common Stock Indirect | 8/18/2026 | S · Sale | −484.00 | $2.01 | $972.84 | 0.1% | 386.34K | 385.86K |
| Total | −1.71K | -$3.44K | ||||||
Derivative Transactions0
No derivative transactions reported